Agilent Technologies and Seoul National University Hospital Collaborate on Biomarker Research

  Agilent Technologies and Seoul National University Hospital Collaborate on
  Biomarker Research

    Goals Include Development, Verification of Biomarkers for Use in Drug
                                 Development

Business Wire

SANTA CLARA, Calif. & SEOUL, South Korea -- October 16, 2013

Agilent Technologies Inc. (NYSE:A) and Seoul National University Hospital,
one of Korea’s top medical centers, today announced a strategic collaboration
for the development and verification of various biomarkers for the development
of drugs, including narcotics, immune-suppressants and biomarkers.

“There are gaps in the medical industry that hamper the quality of care we can
provide to patients,” said Prof. Byung-Hee Oh, president and CEO, Seoul
National University Hospital. “One area we want to address is the development
of biomarkers for early detection and effective monitoring of a range of
diseases.”

“Our hospital is pleased to collaborate with Agilent, the premier test and
measurement company, to help us stretch the horizons of medical research in
order to improve the lives of people in Korea and around the world,” he said.

Under the agreement, the hospital’s Department of Laboratory Medicine will use
the Agilent 6460 Triple Quadrupole LC/MS system as well as Agilent’s support
services and application expertise. The hospital is committed to creating and
maintaining an optimal environment for new biomarkers to be identified and
tested rigorously by highly sensitive yet robust instruments.

“We are privileged to partner with Seoul National University Hospital, which
has a strong tradition of innovation and quality care for customers,” said
Agilent’s Rod Minett, general manager, Life Sciences, South Korea and the
South Asia-Pacific region. “Through this collaboration, we hope to establish
more effective and varied verifications system for the medical and life
sciences industries.”

About Seoul National University Hospital

Seoul National University Hospital has been looking after public health over
the past 100 years, leading the development of medicine in Korea. It was
established in 1885 as Korea’s first national hospital under the name of Kwang
Hye Won. It became the affiliate hospital for Seoul National University’s
College of Medicine and College of Dentistry before being recognized as a
special corporate body under the name of Seoul National University Hospital.
Today, the hospital is comprised of the Main Hospital, the Children’s
Hospital, the Caner Hospital, the Dental Hospital, and the Clinical Research
Institute. For more information, please visit www.snuh.org/english.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company
and a technology leader in chemical analysis, life sciences, diagnostics,
electronics and communications. The company’s 20,500 employees serve customers
in more than 100 countries. Agilent had net revenues of $6.9 billion in fiscal
2012. Information about Agilent is available at www.agilent.com.

NOTE TO EDITORS: Further technology, corporate citizenship and executive news
is available at www.agilent.com/go/news.

Contact:

Agilent
Sui-Ching Low, +65 6215 8975
sui-ching_low@agilent.com
or
SNUH
Jeong Jun Park, +82 2 2072 0077
sogncol@daum.net
 
Press spacebar to pause and continue. Press esc to stop.